# Effects of Dengzhanxixin Capsule on Platelet Function in Individuals at High Risk for Cardiovascular Disease

> **NCT05459519** · NA · UNKNOWN · sponsor: **China National Center for Cardiovascular Diseases** · enrollment: 165 (estimated)

## Conditions studied

- Diabetes
- Hypertension
- Hypercholesterolemia

## Interventions

- **DRUG:** Dengzhanxixin Capsule plus Placebo Capsule
- **DRUG:** Placebo
- **DRUG:** Dengzhanxixin Capsule plus Placebo Capsule

## Key facts

- **NCT ID:** NCT05459519
- **Lead sponsor:** China National Center for Cardiovascular Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-20
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 165 (ESTIMATED)
- **Last updated:** 2023-07-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05459519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05459519, "Effects of Dengzhanxixin Capsule on Platelet Function in Individuals at High Risk for Cardiovascular Disease". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05459519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*